secwatch.observer — SEC 8-K summary
======================================

Issuer:     Concentra Group Holdings Parent, Inc. (CON)
CIK:        0002014596
Form:       8-K
Filed at:   2025-03-03T23:59:59+00:00
Accession:  0002014596-25-000009
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.01, 2.02, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Concentra Q4 revenue +5.5% to $465M, adjusted EBITDA +13.6%; closes $265M Nova acquisition; declares $0.0625 dividend
--------------------------------------------------------------------------------

- Q4 revenue $465.0M (+5.5% YoY); net income $22.8M ($0.17 EPS).
- FY2024 revenue $1,900.2M (+3.4% YoY); adjusted EBITDA $376.9M (+4.3% YoY).
- Closed acquisition of Nova Medical Centers for $265M; adds 67 centers across 5 states.
- 2025 guidance: revenue ~$2.1B, adjusted EBITDA $410-425M; targeting net leverage ~3.0x in 18-24 months.
- Declared quarterly dividend $0.0625/share, payable April 1 to March 18 record date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2014596/000201459625000009/0002014596-25-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2014596/000201459625000009/cghp-20250301.htm
  HTML page:      https://secwatch.observer/filing/0002014596-25-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer